Anti-proliferative action of IL-6R-targeted antibody tocilizumab for non-small cell lung cancer cells.
about
Malignancies in systemic lupus erythematosus: a 2015 update.IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer.Physicochemical and Biological Characterization of the Proposed Biosimilar Tocilizumab.Sustainability of CD24 expression, cell proliferation and migration, cisplatin-resistance, and caspase-3 expression during mesenchymal-epithelial transition induced by the removal of TGF-β1 in A549 lung cancer cells.Diabetes-associated dysregulated cytokines and cancer.
P2860
Anti-proliferative action of IL-6R-targeted antibody tocilizumab for non-small cell lung cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Anti-proliferative action of I ...... -small cell lung cancer cells.
@en
type
label
Anti-proliferative action of I ...... -small cell lung cancer cells.
@en
prefLabel
Anti-proliferative action of I ...... -small cell lung cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Anti-proliferative action of I ...... n-small cell lung cancer cells
@en
P2093
Dong-Soon Kim
Jin-A Park
Jin-Suk Kim
Na-Hyun Kim
Seong-Kwan Kim
P2860
P304
P356
10.3892/OL.2015.3019
P50
P577
2015-03-09T00:00:00Z